Interorgan ammonia metabolism in liver failure
- PMID: 12020618
- DOI: 10.1016/s0197-0186(02)00040-2
Interorgan ammonia metabolism in liver failure
Abstract
In the post-absorptive state, ammonia is produced in equal amounts in the small and large bowel. Small intestinal synthesis of ammonia is related to amino acid breakdown, whereas large bowel ammonia production is caused by bacterial breakdown of amino acids and urea. The contribution of the gut to the hyperammonemic state observed during liver failure is mainly due to portacaval shunting and not the result of changes in the metabolism of ammonia in the gut. Patients with liver disease have reduced urea synthesis capacity and reduced peri-venous glutamine synthesis capacity, resulting in reduced capacity to detoxify ammonia in the liver. The kidneys produce ammonia but adapt to liver failure in experimental portacaval shunting by reducing ammonia release into the systemic circulation. The kidneys have the ability to switch from net ammonia production to net ammonia excretion, which is beneficial for the hyperammonemic patient. Data in experimental animals suggest that the kidneys could have a major role in post-feeding and post-haemorrhagic hyperammonemia.During hyperammonemia, muscle takes up ammonia and plays a major role in (temporarily) detoxifying ammonia to glutamine. Net uptake of ammonia by the brain occurs in patients and experimental animals with acute and chronic liver failure. Concomitant release of glutamine has been demonstrated in experimental animals, together with large increases of the cerebral cortex ammonia and glutamine concentrations. In this review we will discuss interorgan trafficking of ammonia during acute and chronic liver failure. Interorgan glutamine metabolism is also briefly discussed, since glutamine synthesis from glutamate and ammonia is an important alternative pathway of ammonia detoxification. The main ammonia producing organs are the intestines and the kidneys, whereas the major ammonia consuming organs are the liver and the muscle.
Similar articles
-
Interorgan ammonia trafficking in liver disease.Metab Brain Dis. 2009 Mar;24(1):169-81. doi: 10.1007/s11011-008-9122-5. Epub 2008 Dec 9. Metab Brain Dis. 2009. PMID: 19067143 Review.
-
Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.J Clin Invest. 1993 Dec;92(6):2834-40. doi: 10.1172/JCI116903. J Clin Invest. 1993. PMID: 7902848 Free PMC article.
-
Muscle ammonia and glutamine exchange during chronic liver insufficiency in the rat.J Hepatol. 1994 Sep;21(3):299-307. doi: 10.1016/s0168-8278(05)80305-8. J Hepatol. 1994. PMID: 7836697
-
[Disturbances in ammonia metabolism in hepatic failure].Tidsskr Nor Laegeforen. 2007 May 31;127(11):1514-7. Tidsskr Nor Laegeforen. 2007. PMID: 17551556 Review. Norwegian.
-
Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure.Am J Physiol Gastrointest Liver Physiol. 2006 Sep;291(3):G373-81. doi: 10.1152/ajpgi.00440.2005. Epub 2006 Jun 15. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16782695
Cited by
-
Gut microbiota: its role in hepatic encephalopathy.J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S29-36. doi: 10.1016/j.jceh.2014.12.003. Epub 2014 Dec 16. J Clin Exp Hepatol. 2015. PMID: 26041954 Free PMC article. Review.
-
Systems parasitology: effects of Fasciola hepatica on the neurochemical profile in the rat brain.Mol Syst Biol. 2010 Jul;6:396. doi: 10.1038/msb.2010.49. Mol Syst Biol. 2010. PMID: 20664642 Free PMC article.
-
Relationship between the incidence of non-hepatic hyperammonemia and the prognosis of patients in the intensive care unit.World J Gastroenterol. 2020 Dec 7;26(45):7222-7231. doi: 10.3748/wjg.v26.i45.7222. World J Gastroenterol. 2020. PMID: 33362378 Free PMC article. Clinical Trial.
-
Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification.J Biol Chem. 2010 Mar 26;285(13):9516-9524. doi: 10.1074/jbc.M109.092429. Epub 2010 Jan 11. J Biol Chem. 2010. PMID: 20064933 Free PMC article.
-
Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease.Front Med (Lausanne). 2022 May 9;9:841281. doi: 10.3389/fmed.2022.841281. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35615096 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources